ArticleCureus2025
Long-Term Use of Blue Light-Filtering Glasses and Symptom Improvement in Digital Eye Strain: A Questionnaire-Based Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Blue-Light Filters in Eye Care: A State-of-the-Art Review.Medical sciences (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This cross-sectional, questionnaire-based study aimed to evaluate the long-term effectiveness of blue light-filtering (BLF) spectacle lenses in alleviating symptoms of digital eye strain (DES) and to identify behavioral and demographic factors associated with symptom improvement. A total of 186 adults who had worn clear blue-filter lenses for at least 12 months were surveyed regarding the frequency and severity of ocular complaints. Logistic regression analysis identified predictors of symptom improvement, including screen time, adherence to the 20-20-20 rule, and lens use duration. A total of 158 (85.0%) participants reported improvement in at least one symptom, with dryness and eye fatigue being the most frequently improved. Significant predictors of symptom relief included adherence to the 20-20-20 rule (OR = 1.95, p = 0.045), daily screen time under six hours (OR = 0.45, p = 0.027), and lens use for ≥12 months (OR = 1.30, p = 0.040). Female gender and prolonged screen exposure were negatively associated with improvement. As a cross-sectional, self-reported study, the findings reflect subjective recall rather than prospective measurement but suggest that long-term use of clear blue-filter lenses, particularly when combined with visual hygiene practices such as the 20-20-20 rule and screen time moderation, is associated with reduced DES symptoms. The results support the combined use of optical and behavioral strategies in managing screen-related visual discomfort.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.